Broadfin Capital »

Spdr S&p 500 Etf shares owned by Broadfin Capital

Quarter-by-quarter ownership of Spdr S&p 500 Etf (SPY) shares owned by Broadfin Capital from 13F filings

Historical chart of Broadfin Capital investment in Spdr S&p 500 Etf

Tip: Access up to 7 years of quarterly data

All positions including Spdr S&p 500 Etf held by Broadfin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spdr S&p 500 Etf by Broadfin Capital

Quarter filed Position value Share count Share price at filing
2019-12-31 $142M 440k 321.86
2019-09-30 $131M 440k 296.77
2018-12-31 $175M 700k 249.92
2016-06-30 $115M 550k 209.47

More positions owned by Broadfin Capital

Spdr S&p 500 Etf (SPY)
iShares Russell 2000 Index (IWM)
Biohaven Pharmaceutical Holding
SPDR S&P Biotech (XBI)
BioDelivery Sciences International
Alkermes (ALKS)
Viewray (VRAYQ)
Amarin Corporation (AMRN)
Quotient
Eiger Biopharmaceuticals
STAAR Surgical Company (STAA)
Intersect Ent
Progenics Pharmaceuticals
Nanostring Technologies (NSTGQ)
Iovance Biotherapeutics (IOVA)

View all positions for Broadfin Capital

Top funds holding Spdr S&p 500 Etf

Jane Street
Barclays
Citadel Advisors
Susquehanna International
Belvedere Trading
Jpmorgan Chase & Co
Bank of America Corporation
Goldman Sachs Group
Royal Bank of Canada
Wolverine Trading
Vinland Capital Management Gestora de Recursos
UBS Group
Twin Tree Management
Millennium Management
Alkeon Capital Management

View all funds holding Spdr S&p 500 Etf